Executive pay

NewAmsterdam Pharma (NAMS) executive compensation

What NewAmsterdam Pharma Co. N.V. paid its chief executive and named officers, year by year. Figures are automated and can be wrong; check the filing for the exact numbers.

Open NAMS in Gloom →
NewAmsterdam Pharma's chart, financials and news, free in your browser.Open NAMS in Gloom →
  • 2026 proxy statement

    Michael Davidson, M.D. paid $13.6M (+111% on the year), pay ratio 19:1.

    Filed May 06, 2026